BlackRock Institutional Trust’s Dare Bioscience DARE Stock Holding History

BlackRock Institutional Trust’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-519	Closed	-$169K	–	3901
2016 Q1	$169K	Buy	519 +130	+33%	+$36.7K	﹤0.01%	3646
2015 Q4	$131K	Buy	389 +38	+11%	+$15.8K	﹤0.01%	3717
2015 Q3	$154K	Sell	351 -152	-30%	-$76.4K	﹤0.01%	3678
2015 Q2	$277K	Buy	503 +488	+3,253%	+$335K	﹤0.01%	3594
2015 Q1	$16K	Hold	15	–	–	﹤0.01%	3808
2014 Q4	$11K	Hold	15	–	–	﹤0.01%	3853
2014 Q3	$8K	Buy	+15	New	+$7.99K	﹤0.01%	3805

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVMCI

Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock Institutional Trust's DARE Position: Q2 2016 in Review

BlackRock Institutional Trust sold out of Dare Bioscience (DARE) in Q2 2016, closing a stake of 519 shares — an estimated $169K sold.

BlackRock Institutional Trust first reported a position in DARE in Q3 2014 and held it in 7 quarters. The position peaked at $277K in Q2 2015. 34 funds tracked by Wall St. Rank hold DARE as of Q2 2016.

BlackRock Institutional Trust reported no remaining Dare Bioscience position as of Q2 2016 after selling out during the quarter.
BlackRock Institutional Trust sold 519 Dare Bioscience shares in Q2 2016, an estimated $169K.
BlackRock Institutional Trust first reported a position in Dare Bioscience in Q3 2014 and held it in 7 quarters.
BlackRock Institutional Trust's Dare Bioscience position peaked at $277K in Q2 2015.
34 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2016.

Based on BlackRock Institutional Trust's 13F filing for Q2 2016, filed 10 Aug 2016.